Cartilage Repair Market

Cartilage Repair Market / Cartilage Regeneration Market by Treatment Modalities (Cell-Based (Chondrocyte Transplantation, Stem Cells, Growth Factors), Non-Cell (Tissue Scaffolds)), Application (Hyaline, Fibrocartilage), Site, and Region - Global Forecast to 2028

Report Code: BT 4781 Dec, 2023, by marketsandmarkets.com

The global cartilage repair market in terms of revenue was estimated to be worth $1.3 billion in 2023 and is poised to reach $2.8 billion by 2028, growing at a CAGR of 17.2% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Increasing number of osteoarthritis cases, increasing growth opportunities in emerging markets, growing number of Mergers, acquisitions, contracts and agreements between market players and developing healthcare infrastructure.

Attractive Opportunities in the Cartilage Repair Market

Cartilage Regeneration Market

To know about the assumptions considered for the study, Request for Free Sample Report

Cartilage Regeneration Market

Global Cartilage Repair Market Dynamics

Driver: Increasing number of osteoarthritis cases

Over the years, the incidence of osteoarthritis has increased across the globe. According to WHO data from July 2023, about 528 million people worldwide were living with osteoarthritis in 2019, an increase of 113% since 1990. About 73% of people living with osteoarthritis are older than 55 years, and 60% are female. With a prevalence of 365 million, the knee is the most frequently affected joint, followed by the hip and the hand.

According to the Lancet (August 2023), a new study revealed the most common form of arthritis, osteoarthritis, affects 15% of the global population over the age of 30. In 2020, obesity was responsible for approximately 20% of the disability of osteoarthritis. By 2050, nearly 1 billion people are projected to have osteoarthritis.

Some of the most used treatments for osteoarthritis are autologous chondrocyte implantation and scaffold implants. Thus, the increasing incidence of osteoarthritis is expected to drive the demand for cartilage repair and regeneration products.

Restraint: High cost of cartilage repair surgeries

Cartilage repair surgeries are costly though they have better and longer-lasting treatment results as compared to total knee replacement surgeries. As the high cost of cartilage repair therapies is the major factor that is limiting their adoption of the cartilage repair procedures mainly in the developing countries. Therefore, knee replacement procedures average cost is around USD 16,000 where as cartilage repair procedures average cost is approximately USD 18,000–USD 23,000. These barriers may be more pronounced in low-resource settings and developing countries, which is restricting the growth of the cartilage repair market.

Opportunity: Technological advancements

Challenge: Limitations of cartilage-based stem cell products

Clinical research are ongoing to identify an universal source of progenitor cells like embryonic and induced pluripotent stem cells for the treatment of cartilage repair. However, there are challenges associated with their clinical use like immune rejection, tumorigenesis, and teratoma formation as various authorities such as the Human Tissue Authority (HTA), Human Fertilization and Embryology Authority (HFEA), Medicines and Healthcare Products Regulatory Agency (MHRA), and the Central Ethics Committee for Stem Cell Research to monitor these activities have been formulated.  Hence, due to the presence of these regulatory organizations and ethical concerns on the use of embryonic stem cells in research and development is restricted globally.

Cartilage Regeneration Industry Ecosystem

Prominent companies in this market include well-established manufacturers of Cartilage Repair/Cartilage Regeneration Market and offer a wide range of products. These companies have been operating in the market for several years and possess a diversified product portfolio, state-of-the-art technologies, and strong global sales and marketing networks. Prominent companies in this market include Smith+Nephew (UK), DePuy Synthes (Johnson & Johnson) (US), Zimmer Biomet Holdings, Inc. (US), Stryker Corporation (US), and Vericel Corporation (US)

Cartilage Regeneration Market Ecosystem

In 2022, Hyaline Cartilage segment to observe highest growth rate of the cartilage regeneration industry, by Application.

Based on the Application, The cartilage repair market, by application, has been segmented into Hyaline Cartilage and Fibrocartilage. Hyaline Cartilage will drive the growth of the market due to growing number of contracts and agreements between key market players and the availability of funding and rising investment in the research and development of the advancement of tissue-engineered products for the treatment of cartilage injury/damage.

In 2022, Knee segment to dominate the cartilage repair industry, by the Application site.

Based on Application site, the cartilage regeneration market is segmented knee, hip, Ankle and foot and other application site. Knee segment is expected to grow highest due to the increasing number of Knee arthroscopy procedures. As Arthroscopic surgery is often used for cartilage reattachment as well as the microfracture technique.

In 2022, North America to dominate the cartilage repair industry, by the Application site as knee segment had the highest growth the region.

Cartilage Repair Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The cartilage repair market is dominated by players such  as Smith+Nephew (UK), DePuy Synthes (Johnson & Johnson) (US), Zimmer Biomet Holdings, Inc. (US), Stryker Corporation (US), and Vericel Corporation (US).

Scope of the Cartilage Repair Industry

Report Metric

Details

Market Revenue in 2023

$1.3 billion

Projected Revenue by 2028

$2.8 billion

Revenue Rate

Poised to Grow at a CAGR of 17.2%

Market Driver

Increasing number of osteoarthritis cases

Market Opportunity

Technological advancements

This research report categorizes the cartilage regeneration market into the following segments and subsegments:

TYPE

PARAMETER

By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

By Treatment Modality

  • Cell-based
    • Chondrocyte Transplantation
    • Stem Cells
    • Growth Factors
  • Non-cell-based
    • Tissue Scaffolds
    • Cell-free Composites

By Application

  • Knee
  • Hip
  • Ankle and Foot
  • Other Application Sites

By Application Site

  • Hyaline Cartilage
  • Fibrocartilage

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 23)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
          TABLE 1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED
           1.3.3 CURRENCY CONSIDERED
    1.4 STAKEHOLDERS 
    1.5 SUMMARY OF CHANGES 
           1.5.1 RECESSION IMPACT
 
2 RESEARCH METHODOLOGY (Page No. - 26)
    2.1 RESEARCH DATA 
          FIGURE 1 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET: RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 2 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
                    2.1.2.3 Breakdown of primary interviews
                                FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION 
           2.2.1 APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH
                    FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION
           2.2.2 APPROACH 2: CALCULATING MARKET SIZE FROM NUMBER OF CARTILAGE REPAIR TREATMENT PROCEDURES
                    TABLE 2 REVENUE ESTIMATION APPROACH BY CALCULATING NUMBER OF CARTILAGE REPAIR TREATMENTS PROCEDURES IN US
           2.2.3 APPROACH 3: CORPORATE PRESENTATIONS OF COMPANIES AND PRIMARY INTERVIEWS
           2.2.4 APPROACH 4: PRIMARY INTERVIEWS
           2.2.5 APPROACH 5: FINAL MARKET CALCULATION
                    FIGURE 5 GROWTH FORECAST
                    FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
                    FIGURE 7 TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN & DATA TRIANGULATION 
          FIGURE 8 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ANALYSIS 
    2.5 MARKET ASSUMPTIONS 
    2.6 RISK ASSESSMENT 
    2.7 LIMITATIONS 
    2.8 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET: RECESSION IMPACT ANALYSIS 
 
3 EXECUTIVE SUMMARY (Page No. - 38)
    FIGURE 9 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2023 VS. 2028 (USD MILLION)
    FIGURE 10 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    FIGURE 11 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2023 VS. 2028 (USD MILLION)
    FIGURE 12 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET: GEOGRAPHIC SNAPSHOT
 
4 PREMIUM INSIGHTS (Page No. - 41)
    4.1 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET OVERVIEW 
          FIGURE 13 INCREASING INCIDENCE OF OSTEOARTHRITIS TO DRIVE MARKET
    4.2 NORTH AMERICA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION AND COUNTRY, 2022 
          FIGURE 14 HYALINE CARTILAGE HELD LARGEST SHARE IN 2022
    4.3 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 15 JAPAN TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 43)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 16 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 MARKET DRIVERS
                    5.2.1.1 Increasing incidence of osteoarthritis
                    5.2.1.2 Increasing research funding and investments
                    5.2.1.3 Rising number of sports and accident-related orthopedic injuries
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of cartilage repair surgeries
                    5.2.2.2 Unfavorable reimbursement scenario
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Technological advancements
                    5.2.3.2 Developments in regenerative medicine
           5.2.4 CHALLENGES
                    5.2.4.1 Limitations of cartilage-based stem cell products
                    5.2.4.2 Need for skilled personnel
    5.3 SUPPLY CHAIN ANALYSIS 
          FIGURE 17 DISTRIBUTION—KEY STRATEGY PREFERRED BY PROMINENT COMPANIES
    5.4 REGULATORY LANDSCAPE 
           5.4.1 INTRODUCTION
           5.4.2 NORTH AMERICA
                    TABLE 3 CLASSIFICATION BASED ON SUBMISSION REQUIRED FOR REGULATORY APPROVAL
           5.4.3 EUROPE
           5.4.4 ASIA PACIFIC
    5.5 PATENT ANALYSIS 
          FIGURE 18 PATENT ANALYSIS FOR CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET
    5.6 PIPELINE ANALYSIS 
           5.6.1 PIPELINE ANALYSIS, BY CLINICAL TRIAL PHASE
                    FIGURE 19 CARTILAGE REPAIR CANDIDATE PRODUCTS IN CLINICAL PHASES ONE TO FOUR
                    TABLE 4 INDICATIVE LIST OF CANDIDATES IN CLINICAL TRIALS
    5.7 TECHNOLOGY ANALYSIS 
 
6 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY (Page No. - 55)
    6.1 INTRODUCTION 
          TABLE 5 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021–2028 (USD MILLION)
    6.2 CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION 
          TABLE 6 CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 7 CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY REGION, 2021–2028 (USD MILLION)
          TABLE 8 NORTH AMERICA: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 9 EUROPE: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 10 ASIA PACIFIC: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.1 CHONDROCYTE TRANSPLANTATION
                    6.2.1.1 Cost-effectiveness to support market growth
                                TABLE 11 CHONDROCYTE TRANSPLANTATION MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 12 NORTH AMERICA: CHONDROCYTE TRANSPLANTATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.2 GROWTH FACTORS
                    6.2.2.1 Promising results associated with growth factors to drive market
                                TABLE 13 GROWTH FACTORS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 14 NORTH AMERICA: GROWTH FACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.3 STEM CELLS
                    6.2.3.1 Advancements in stem cell-based tissue engineering to support market growth
                                TABLE 15 STEM CELLS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 16 NORTH AMERICA: STEM CELLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    6.3 NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION 
          TABLE 17 NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 18 NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY REGION, 2021–2028 (USD MILLION)
          TABLE 19 NORTH AMERICA: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 20 EUROPE: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 21 ASIA PACIFIC: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.1 TISSUE SCAFFOLDS
                    6.3.1.1 Benefits of one-step procedure likely to boost market growth
                                TABLE 22 TISSUE SCAFFOLDS MARKET, BY REGION, 2021–2028 (USD MILLION)
           6.3.2 CELL-FREE COMPOSITES
                    6.3.2.1 Increasing research to support market growth
                                TABLE 23 CELL-FREE COMPOSITES MARKET, BY REGION, 2021–2028 (USD MILLION)
 
7 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE (Page No. - 65)
    7.1 INTRODUCTION 
          TABLE 24 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021–2028 (USD MILLION)
    7.2 KNEE 
           7.2.1 INCREASING CASES OF KNEE ARTHROSCOPY TO DRIVE MARKET GROWTH
                    TABLE 25 KNEE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 26 NORTH AMERICA: KNEE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 27 EUROPE: KNEE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 28 ASIA PACIFIC: KNEE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    7.3 HIP 
           7.3.1 INCREASING ADOPTION OF MINIMALLY INVASIVE ARTHROSCOPY PROCEDURES TO SUPPORT MARKET GROWTH
                    TABLE 29 HIP CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 30 NORTH AMERICA: HIP CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 31 EUROPE: HIP CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 32 ASIA PACIFIC: HIP CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    7.4 ANKLE & FOOT 
           7.4.1 INCREASING SPORTS INJURIES TO DRIVE DEMAND
                    TABLE 33 ANKLE & FOOT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 34 NORTH AMERICA: ANKLE & FOOT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 35 EUROPE: ANKLE & FOOT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    7.5 OTHER APPLICATION SITES 
          TABLE 36 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET FOR OTHER APPLICATION SITES, BY REGION, 2021–2028 (USD MILLION)
          TABLE 37 NORTH AMERICA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET FOR OTHER APPLICATION SITES, BY COUNTRY, 2021–2028 (USD MILLION)
 
8 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION (Page No. - 73)
    8.1 INTRODUCTION 
          TABLE 38 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
    8.2 HYALINE CARTILAGE 
           8.2.1 HYALINE CARTILAGE SEGMENT TO HOLD LARGER MARKET SHARE
                    TABLE 39 HYALINE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 40 NORTH AMERICA: HYALINE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 41 EUROPE: HYALINE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 42 ASIA PACIFIC: HYALINE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    8.3 FIBROCARTILAGE 
           8.3.1 SUPPORT AND STRENGTH ADVANTAGES FOR SURROUNDING STRUCTURES TO DRIVE MARKET
                    TABLE 43 FIBROCARTILAGE REPAIR/REGENERATION MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 44 NORTH AMERICA: FIBROCARTILAGE REPAIR/REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 45 EUROPE: FIBROCARTILAGE REPAIR/REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 46 ASIA PACIFIC: FIBROCARTILAGE REPAIR/REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
 
9 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY REGION (Page No. - 78)
    9.1 INTRODUCTION 
          TABLE 47 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY REGION, 2021–2028 (USD MILLION)
    9.2 NORTH AMERICA 
           9.2.1 NORTH AMERICA: RECESSION IMPACT
                    FIGURE 20 NORTH AMERICA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SNAPSHOT
                    TABLE 48 NORTH AMERICA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 49 NORTH AMERICA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021–2028 (USD MILLION)
                    TABLE 50 NORTH AMERICA: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 51 NORTH AMERICA: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 52 NORTH AMERICA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                    TABLE 53 NORTH AMERICA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021–2028 (USD MILLION)
           9.2.2 US
                    9.2.2.1 Increasing incidence of osteoporosis to drive market
                                TABLE 54 US: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021–2028 (USD MILLION)
                                TABLE 55 US: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 56 US: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 57 US: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 58 US: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021–2028 (USD MILLION)
           9.2.3 CANADA
                    9.2.3.1 Increasing investments in regenerative medicine research to drive market
                                TABLE 59 CANADA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021–2028 (USD MILLION)
                                TABLE 60 CANADA: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 61 CANADA: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 62 CANADA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 63 CANADA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021–2028 (USD MILLION)
    9.3 EUROPE 
           9.3.1 EUROPE: RECESSION IMPACT
                    TABLE 64 EUROPE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 65 EUROPE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021–2028 (USD MILLION)
                    TABLE 66 EUROPE: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 67 EUROPE: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 68 EUROPE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                    TABLE 69 EUROPE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021–2028 (USD MILLION)
           9.3.2 GERMANY
                    9.3.2.1 Strong R&D base and focus on minimally invasive surgeries to support market growth
                                TABLE 70 GERMANY: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021–2028 (USD MILLION)
                                TABLE 71 GERMANY: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 72 GERMANY: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 73 GERMANY: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 74 GERMANY: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021–2028 (USD MILLION)
           9.3.3 UK
                    9.3.3.1 Rising prevalence of joint diseases to boost demand
                                TABLE 75 UK: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021–2028 (USD MILLION)
                                TABLE 76 UK: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 77 UK: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 78 UK: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 79 UK: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021–2028 (USD MILLION)
           9.3.4 FRANCE
                    9.3.4.1 Rising degenerative disease and healthcare expenditure to drive market
                                TABLE 80 FRANCE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021–2028 (USD MILLION)
                                TABLE 81 FRANCE: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 82 FRANCE: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 83 FRANCE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 84 FRANCE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021–2028 (USD MILLION)
           9.3.5 REST OF EUROPE
                    TABLE 85 REST OF EUROPE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021–2028 (USD MILLION)
                    TABLE 86 REST OF EUROPE: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 87 REST OF EUROPE: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 88 REST OF EUROPE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                    TABLE 89 REST OF EUROPE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021–2028 (USD MILLION)
    9.4 ASIA PACIFIC 
           9.4.1 ASIA PACIFIC: RECESSION IMPACT
                    FIGURE 21 ASIA PACIFIC: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET
                    TABLE 90 ASIA PACIFIC: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 91 ASIA PACIFIC: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021–2028 (USD MILLION)
                    TABLE 92 ASIA PACIFIC: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 93 ASIA PACIFIC: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 94 ASIA PACIFIC: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                    TABLE 95 ASIA PACIFIC: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021–2028 (USD MILLION)
           9.4.2 JAPAN
                    9.4.2.1 Japan to hold largest market share throughout forecast period
                                TABLE 96 JAPAN: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021–2028 (USD MILLION)
                                TABLE 97 JAPAN: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 98 JAPAN: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 99 JAPAN: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 100 JAPAN: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021–2028 (USD MILLION)
           9.4.3 CHINA
                    9.4.3.1 China to register highest growth in APAC market
                                TABLE 101 CHINA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021–2028 (USD MILLION)
                                TABLE 102 CHINA: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 103 CHINA: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 104 CHINA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 105 CHINA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021–2028 (USD MILLION)
           9.4.4 INDIA
                    9.4.4.1 Rising number of hospitals and developing healthcare infrastructure to propel market growth
                                TABLE 106 INDIA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021–2028 (USD MILLION)
                                TABLE 107 INDIA: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 108 INDIA: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 109 INDIA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 110 INDIA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021–2028 (USD MILLION)
           9.4.5 REST OF ASIA PACIFIC
                    TABLE 111 REST OF ASIA PACIFIC: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021–2028 (USD MILLION)
                    TABLE 112 REST OF ASIA PACIFIC: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 113 REST OF ASIA PACIFIC: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 114 REST OF ASIA PACIFIC: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                    TABLE 115 REST OF ASIA PACIFIC: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021–2028 (USD MILLION)
    9.5 REST OF THE WORLD 
           9.5.1 REST OF THE WORLD: RECESSION IMPACT
                    TABLE 116 REST OF THE WORLD: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021–2028 (USD MILLION)
                    TABLE 117 REST OF THE WORLD: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 118 REST OF THE WORLD: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 119 REST OF THE WORLD: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                    TABLE 120 REST OF THE WORLD: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021–2028 (USD MILLION)
 
10 COMPETITIVE LANDSCAPE (Page No. - 112)
     10.1 INTRODUCTION 
     10.2 REVENUE ANALYSIS 
             FIGURE 22 TOP FIVE PLAYERS HAVE DOMINATED MARKET IN LAST FIVE YEARS
     10.3 MARKET SHARE ANALYSIS 
             FIGURE 23 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET: MARKET SHARE ANALYSIS, 2022
             TABLE 121 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET: DEGREE OF COMPETITION
     10.4 COMPANY EVALUATION MATRIX 
             10.4.1 STARS
             10.4.2 EMERGING LEADERS
             10.4.3 PERVASIVE PLAYERS
             10.4.4 PARTICIPANTS
                        FIGURE 24 GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET: COMPANY EVALUATION MATRIX, 2022
     10.5 COMPETITIVE SCENARIO 
             10.5.1 PRODUCT APPROVALS
                       TABLE 122 KEY PRODUCT APPROVALS, JANUARY 2020–NOVEMBER 2023
             10.5.2 DEALS
                       TABLE 123 KEY DEALS, JANUARY 2020–NOVEMBER 2023
             10.5.3 OTHER DEVELOPMENTS
                       TABLE 124 OTHER KEY DEVELOPMENTS, JANUARY 2020–NOVEMBER 2023
 
11 COMPANY PROFILES (Page No. - 119)
     11.1 KEY COMPANIES 
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             11.1.1 SMITH+NEPHEW
                       TABLE 125 SMITH+NEPHEW: COMPANY OVERVIEW
                       FIGURE 25 SMITH+NEPHEW: COMPANY SNAPSHOT (2022)
             11.1.2 DEPUY SYNTHES (JOHNSON & JOHNSON)
                       TABLE 126 JOHNSON & JOHNSON: COMPANY OVERVIEW
                       FIGURE 26 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2022)
             11.1.3 ZIMMER BIOMET HOLDINGS, INC.
                       TABLE 127 ZIMMER BIOMET HOLDINGS, INC.: COMPANY OVERVIEW
                       FIGURE 27 ZIMMER BIOMET HOLDINGS, INC.: COMPANY SNAPSHOT (2022)
             11.1.4 STRYKER CORPORATION
                       TABLE 128 STRYKER CORPORATION: COMPANY OVERVIEW
                       FIGURE 28 STRYKER CORPORATION: COMPANY SNAPSHOT (2022)
             11.1.5 VERICEL CORPORATION
                       TABLE 129 VERICEL CORPORATION: COMPANY OVERVIEW
                       FIGURE 29 VERICEL CORPORATION: COMPANY SNAPSHOT (2022)
             11.1.6 B. BRAUN MELSUNGEN AG
                       TABLE 130 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW
                       FIGURE 30 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2022)
             11.1.7 ANIKA THERAPEUTICS, INC.
                       TABLE 131 ANIKA THERAPEUTICS, INC.: COMPANY OVERVIEW
                       FIGURE 31 ANIKA THERAPEUTICS, INC: COMPANY SNAPSHOT (2022)
             11.1.8 RTI SURGICAL
                       TABLE 132 RTI SURGICAL: COMPANY OVERVIEW
             11.1.9 CONMED CORPORATION
                       TABLE 133 CONMED CORPORATION.: COMPANY OVERVIEW
                       FIGURE 32 CONMED CORPORATION: COMPANY SNAPSHOT (2022)
             11.1.10 ARTHREX INC.
                       TABLE 134 ARTHREX INC.: COMPANY OVERVIEW
             11.1.11 REGROW BIOSCIENCES
                       TABLE 135 REGROW BIOSCIENCES: COMPANY OVERVIEW
             11.1.12 MEDIPOST
                       TABLE 136 MEDIPOST: COMPANY OVERVIEW
                       FIGURE 33 MEDIPOST: COMPANY SNAPSHOT (2022)
     11.2 OTHER PLAYERS 
             11.2.1 GEISTLICH PHARMA AG
             11.2.2 ALLOSOURCE
             11.2.3 ORTHOCELL LTD.
             11.2.4 CARTIHEAL, INC.
             11.2.5 REGENTIS BIOMATERIALS
             11.2.6 LIFENET HEALTH
             11.2.7 MATRICEL GMBH
             11.2.8 THERACELL ADVANCED BIOTECHNOLOGY
 
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
 
12 APPENDIX (Page No. - 154)
     12.1 DISCUSSION GUIDE 
     12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     12.3 CUSTOMIZATION OPTIONS 
     12.4 RELATED REPORTS 
     12.5 AUTHOR DETAILS 

The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the cartilage repair/cartilage regeneration market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.

The four steps involved in estimating the market size are:

Collecting Secondary Data

The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the cartilage repair/cartilage regeneration market. A database of the key industry leaders was also prepared using secondary research.

Collecting Primary Data

The primary research data was collected after acquiring knowledge about the cartilage repair/cartilage regeneration market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as Hospitals) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing, and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific and Rest of the world. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

A breakdown of the primary respondents is provided below:

Breakdown of Primary Participants:

Cartilage Repair/Cartilage Regeneration Market Size, and Share

Note 1: *Others include sales managers, marketing managers, and product managers.

Note 2: Tiers are defined based on a company’s total revenue as of 2022: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

COMPANY NAME

DESIGNATION

Vericel Corporation (US)

Product Manager

Zimmer Biomet Holdings, Inc. (US)

Regional Manager

Smith+Nephew (UK)

Regional Business Head

Market Size Estimation

All major product manufacturers offering various cartilage repair/cartilage regeneration markets were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value cartilage repair/cartilage regeneration market was also split into various segments and subsegments at the regional and country levels based on the following:

  • Product mapping of various manufacturers for each solution of cartilage repair/cartilage regeneration market at the regional and country-level 
  • Relative adoption pattern of each cartilage repair/cartilage regeneration market among key application segments at the regional and/or country-level 
  • Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country level. 
  • Detailed secondary research to gauge the prevailing market trends at the regional and/or country level

Global Cartilage Repair/Cartilage Regeneration Market Size: Botton-Up Approach

Cartilage Repair/Cartilage Regeneration Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Cartilage Repair/Cartilage Regeneration Market Size: Top-Down Approach

Cartilage Repair/Cartilage Regeneration Market Size, and Share

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the cartilage repair/cartilage regeneration market.

Market Definition

Cartilage repair refers to the process of restoring damaged or injured cartilage tissue, which is a tough, flexible connective tissue found in various parts of the body, including joints. Cartilage does not have a direct blood supply, which makes its natural healing capacity limited. Therefore, injuries to cartilage often result in pain and limited joint function. The cartilage tissue is made of specialized cells called chondrocytes. Cartilage injuries are most commonly observed in athletes and individuals with an active lifestyle. As cartilage is avascular and does not have a blood supply, cartilage repair and regeneration is one of the most challenging medical treatments. Cartilage repair treatment involves the repair, removal, replacement, or restoration of the surface of articular cartilage.

Key Stakeholders

  • Senior Management
  • End User
  • Finance/Procurement Department
  • R&D Department

Report Objectives

  • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To define, describe, segment, and forecast the cartilage repair/cartilage regeneration market by Product, Application, Medical specialty and Region
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall cartilage repair/cartilage regeneration market
  • To forecast the size of the cartilage repair/cartilage regeneration market in four main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, and Rest of the world
  • To profile key players in the cartilage repair/cartilage regeneration market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments, such as acquisitions; product launches; expansions; collaborations, agreements, & partnerships; and R&D activities of the leading players in the cartilage repair/cartilage regeneration market.
  • To benchmark players within the cartilage repair/cartilage regeneration market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy.

Available Customizations

MarketsandMarkets offers the following customizations for this market report:

  • Additional country-level analysis of the cartilage repair/cartilage regeneration market
  • Profiling of additional market players (up to 5)  Product Analysis
  • Product matrix, which provides a detailed comparison of the product portfolio of each company in the cartilage repair/cartilage regeneration market
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
BT 4781
Published ON
Dec, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Cartilage Repair Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback